Use of Cardiotrophin-1 as a Biomarker of Cellular Senescence in Estrogen Receptor Positive Breast Cancer Cells


Özdemir A., Tayyar T., Ark M., Şimay Demir Y. D.

Patent, CHAPTER A Human Needs, The Invention Registration Number: 2024/006099 , Standard Registration, 2024, 2026, Registered / Approved

  • Intellectual Property: Patent
  • Country/Organization of Application: Turkey
  • Status of The Invention: Pending / Applied
  • Recourse Date: 5/17/2024
  • Country/Organization of Application: Turkey
  • Status of The Invention: Registered / Approved
  • Recourse Date: 5/17/2024
  • Registration Date: 1/21/2026